Related Experiment Video
Updated: May 9, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Strategies in the development of vaccines to prevent infections with group A streptococcus
Michael F Good1, Michael R Batzloff, Manisha Pandey
1Institute for Glycomics; Griffith University, Gold Coast campus; QLD Australia.
Abstract:
There has long been interest and demand for the development of a vaccine to prevent infections caused by the Gram-positive organism group A streptococcus. Despite numerous efforts utilizing advanced approaches such as genomics, proteomics and bio-informatics, there is currently no vaccine. Here we review various strategies employed to achieve this goal. We also discuss the approach that we have pursued, a non-host reactive, conformationally constrained minimal B cell epitope from within the C-repeat region of M-protein, and the potential limitations in moving forward.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Vaccines
Vaccine Production
Vaccinations
Microorganisms in Medicine and Therapeutics
Inhibitors of Gram-positive Cell Wall Synthesis